Bipartisan, Bicameral Bill Would Add Pharmacist Services to Medicare
Thu, 26 Feb 2015 00:00:00 -0500
On back-to-back legislative days in late January, Democratic and Republican representatives and senators in Congress introduced the Pharmacy and Medically Underserved Areas Enhancement Act.
Heritage Recalls Colistimethate, Rifampin Vials
Heritage Pharmaceuticals Inc. (PDF)
on Tuesday announced it was recalling 10 lots of colistimethate and 3 lots of rifampin vials because an FDA inspection of the manufacturer's site revealed practices that could affect product sterility.
Sagent Recalls Atracurium Vials
Tue, 24 Feb 2015 00:00:00 -0500
Sagent Pharmaceuticals Inc.
on Monday announced it was recalling six lots of atracurium besylate 10-mg/mL injection vials because an FDA inspection of the contract manufacturer's site revealed practices that could affect product sterility.
HDAC Inhibitor Approved for Multiple Myeloma
FDA and Novartis on Monday announced the approval of panobinostat, a histone deacetylase (HDAC) inhibitor, for the third-line treatment of multiple myeloma.
CMS Tells Prescribing Pharmacists: Don't Enroll in Medicare for Now
Mon, 23 Feb 2015 00:00:00 -0500
Even though the Centers for Medicare and Medicaid Services (CMS) wants to restrict coverage of Part D prescriptions to those written by healthcare professionals enrolled in Medicare, the agency hasn't figured out what to do about pharmacists with prescribing authority.